Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of Chang-Ji-An Capsule for diarrhea-predominant irritable bowel syndrome
CTR20261671Phase 3Active
- Sponsor
- First Affiliated Hospital of Guangzhou University of Chinese Medicine
- Start
- Jun 2026
- Countries
- 1
01
Overview
A Phase 3 trial of Changji'an Capsule in Diarrhea-predominant irritable bowel syndrome (IBS-D), sponsored by First Affiliated Hospital of Guangzhou University of Chinese Medicine. Started Jun 2026; status: active.
02
Drugs
Changji'an Capsule
03
Conditions
Diarrhea-predominant irritable bowel syndrome (IBS-D)
Beyond the preview
Go deeper on CTR20261671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261671.